99 related articles for article (PubMed ID: 8097596)
1. Locomotor activity following intra-accumbens microinjections of dopamine D1 agonist SK&F 38393 in rats.
Meyer ME; Van Hartesveldt C; Potter TJ
Synapse; 1993 Apr; 13(4):310-4. PubMed ID: 8097596
[TBL] [Abstract][Full Text] [Related]
2. Effects of intraaccumbens dopamine agonist SK&F38393 and antagonist SCH23390 on locomotor activities in rats.
Meyer ME
Pharmacol Biochem Behav; 1993 Aug; 45(4):843-7. PubMed ID: 8105489
[TBL] [Abstract][Full Text] [Related]
3. Hippocampal modulation of locomotor activity induced by focal activation of postsynaptic dopamine receptors in the core of the nucleus accumbens.
Rouillon C; Abraini JH; David HN
Hippocampus; 2007; 17(11):1028-36. PubMed ID: 17604350
[TBL] [Abstract][Full Text] [Related]
4. A vehicle injection into the right core of the nucleus accumbens both reverses the region-specificity and alters the type of contralateral turning elicited by unilateral stimulation of dopamine D2/D3 and D1 receptors in the left core of the nucleus accumbens.
Ikeda H; Kotani A; Koshikawa N; Cools AR
Eur J Pharmacol; 2007 Dec; 577(1-3):64-70. PubMed ID: 17884038
[TBL] [Abstract][Full Text] [Related]
5. Dynamic dopamine receptor interactions in the core and shell of nucleus accumbens differentially coordinate the expression of unconditioned motor behaviors.
Canales JJ; Iversen SD
Synapse; 2000 Jun; 36(4):297-306. PubMed ID: 10819907
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D1 receptor family agonists, SK&F38393, SK&F77434, and SK&F82958, differentially affect locomotor activities in rats.
Meyer ME; Shults JM
Pharmacol Biochem Behav; 1993 Oct; 46(2):269-74. PubMed ID: 7903456
[TBL] [Abstract][Full Text] [Related]
7. Super-stereotypy II: enhancement of a complex movement sequence by intraventricular dopamine D1 agonists.
Berridge KC; Aldridge JW
Synapse; 2000 Sep; 37(3):205-15. PubMed ID: 10881042
[TBL] [Abstract][Full Text] [Related]
8. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
Schmidt HD; Pierce RC
Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308
[TBL] [Abstract][Full Text] [Related]
9. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
Neal-Beliveau BS; Joyce JN
Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220
[TBL] [Abstract][Full Text] [Related]
10. Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats.
Dreher JK; Jackson DM
Brain Res; 1989 May; 487(2):267-77. PubMed ID: 2525062
[TBL] [Abstract][Full Text] [Related]
11. SK&F 83822 distinguishes adenylyl cyclase from phospholipase C-coupled dopamine D1-like receptors: behavioural topography.
O'Sullivan GJ; Roth BL; Kinsella A; Waddington JL
Eur J Pharmacol; 2004 Feb; 486(3):273-80. PubMed ID: 14985049
[TBL] [Abstract][Full Text] [Related]
12. Dopamine D1 receptor stimulation of the nucleus accumbens or the medial preoptic area promotes the onset of maternal behavior in pregnancy-terminated rats.
Stolzenberg DS; McKenna JB; Keough S; Hancock R; Numan MJ; Numan M
Behav Neurosci; 2007 Oct; 121(5):907-19. PubMed ID: 17907823
[TBL] [Abstract][Full Text] [Related]
13. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M
Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
[TBL] [Abstract][Full Text] [Related]
14. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat.
Campbell BM; Kreipke CW; Walker PD
Neuroscience; 2006; 137(2):505-17. PubMed ID: 16289829
[TBL] [Abstract][Full Text] [Related]
15. SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat.
Le Monnier de Gouville AC; Lawson K; Thiry C; Cavero I
J Pharmacol Exp Ther; 1991 Mar; 256(3):1049-56. PubMed ID: 1672375
[TBL] [Abstract][Full Text] [Related]
16. Disruption of G(i/o) protein signaling in the nucleus accumbens results in a D1 dopamine receptor-mediated hyperactivity.
Schroeder JA; Hummel M; Unterwald EM
Pharmacol Biochem Behav; 2004 Sep; 79(1):93-9. PubMed ID: 15388288
[TBL] [Abstract][Full Text] [Related]
17. Suppression of natural killer cell activity by morphine is mediated by the nucleus accumbens shell.
Saurer TB; Carrigan KA; Ijames SG; Lysle DT
J Neuroimmunol; 2006 Apr; 173(1-2):3-11. PubMed ID: 16364456
[TBL] [Abstract][Full Text] [Related]
18. Super-stereotypy I: enhancement of a complex movement sequence by systemic dopamine D1 agonists.
Berridge KC; Aldridge JW
Synapse; 2000 Sep; 37(3):194-204. PubMed ID: 10881041
[TBL] [Abstract][Full Text] [Related]
19. Repeated intra-ventral tegmental area administration of SKF-38393 induces behavioral and neurochemical sensitization to a subsequent cocaine challenge.
Pierce RC; Born B; Adams M; Kalivas PW
J Pharmacol Exp Ther; 1996 Jul; 278(1):384-92. PubMed ID: 8764374
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of quinpirole in the nucleus accumbens depending on the initial level of locomotor activity.
Wu M; Brudzynski SM; Mogenson GJ
Brain Res Bull; 1993; 32(4):395-8. PubMed ID: 8106125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
